2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study
Conclusions. Two doses of Vigoo EV71 vaccine could provide sustained protection against EV71-associated HFMD in healthy Chinese children.
Clinical Trials Registration. NCT01508247.
Source: The Journal of Infectious Diseases - Category: Infectious Diseases Authors: Wei, M., Meng, F., Wang, S., Li, J., Zhang, Y., Mao, Q., Hu, Y., Liu, P., Shi, N., Tao, H., Chu, K., Wang, Y., Liang, Z., Li, X., Zhu, F. Tags: VIRUSES Source Type: research
More News: Children | Clinical Trials | Enterovirus | Hand, Foot and Mouth | Infectious Diseases | Men | Study | Vaccines